MedTrace Logo

Clinical Trial Comparing Dose-intensified SBRT With Conventional Radiation Therapy for Spinal Metastases

NCT02800551 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 219

Last updated 2026-01-29

No results posted yet for this study

Summary

This study will compare pain (primary end-point) and local metastatic tumor control (secondary end-point) after dose-intensified image-guided fractionated stereotactic body radiation therapy (SBRT) for painful mass-type spinal metastases versus conventional radiation therapy.

Conditions

  • Spinal Metastasis

Interventions

RADIATION

dose-intensified image-guided SBRT using simultaneous integrated boost

RADIATION

External 3-dimensional conformal radiotherapy (3D-CRT)

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Principal Investigators

  • Matthias Guckenberger, Prof. Dr. · Universitätsspital Zürich

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-08
Primary Completion
2023-01-13
Completion
2024-03-12

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02800551 on ClinicalTrials.gov